P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS

P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Marko Lucijanic, Petra Bistrovic, Ana Jordan, Iva Mihaljevic, Stela Bukvic, Stjepan Kovacevic, Darjan Ranilovic, Sara Sakota, Josipa Vlasac Glasnovic, Diana Delic-Brkljacic
التنسيق: مقال
اللغة:English
منشور في: Wiley 2023-08-01
سلاسل:HemaSphere
الوصول للمادة أونلاين:http://journals.lww.com/10.1097/01.HS9.0000973128.79769.f1

الانترنت

http://journals.lww.com/10.1097/01.HS9.0000973128.79769.f1

مواد مشابهة